Michael P. Plant
Known title: EVP, DevelopmentCIK: 0002036190
Associated companies
Transaction History
| BATRA | ▼ Sell | Open Market | 4,874 | $194K | 12/12/2025 | View on chart |
| BATRA | ▲ Buy | Option Exercise | 11,142 | $0 | 12/11/2025 | View on chart |
| BATRA | ▼ Sell | Open Market | 8,893 | $344K | 12/5/2025 | View on chart |
| BATRA | ▲ Buy | Option Exercise | 20,000 | $0 | 12/4/2025 | View on chart |
| BATRA | ▼ Sell | Open Market | 69,000 | $3.0M | 6/11/2025 | View on chart |
| BATRA | ▼ Sell | Open Market | 14,940 | $597K | 12/12/2024 | View on chart |
| BATRA | ▲ Buy | Option Exercise | 22,284 | $0 | 12/11/2024 | View on chart |
| BATRA | ▲ Buy | Option Exercise | 11,142 | $0 | 12/11/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
CME Group to Launch Baseball Futures; Braves Holdings Reports Q2 2026 Results
CME Group will begin trading baseball futures on Oct. 12, adding a new product that could influence the Braves’ valuation. Braves Holdings released its Q2 2026 earnings, detailing revenue and operating metrics. A SeekingAlpha piece notes that a looming strike may reduce the likelihood of a short‑term rally for the company. The stock sits near its 52‑week range and is holding support at $56.50.
CME Group to Launch Baseball Futures; Braves Holdings Reports Q2 2026 Results. CME Group will begin trading baseball futures on Oct. 12, adding a new product that could influence the Braves’ valuation. Braves Holdings released its Q2 2026 earnings, detailing revenue and operating metrics. A SeekingAlpha piece notes that a looming strike may reduce the likelihood of a short‑term rally for the company. The stock sits near its 52‑week range and is holding support at $56.50.